| [February 03, 2016] |
 |
Cardiovascular Systems to Present at LEERINK Partners 5th Annual Global Healthcare Conference
On Wednesday, February 10, 2016, Cardiovascular Systems' (NASDAQ: CSII)
Chief Financial Officer, Larry Betterley, will present at the LEERINK
Partners 5th Annual Global Healthcare Conference at 2:40 p.m.
Eastern Time.
You may access the live audio webcast and presentation materials in the
Investors section at: www.csi360.com.
Presentation materials also will be archived on CSI's (News - Alert) website.
About Cardiovascular Systems, Inc.
Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device compay focused on
developing and commercializing innovative solutions for treating
vascular and coronary disease. The company's Orbital Atherectomy Systems
treat calcified and fibrotic plaque in arterial vessels throughout the
leg and heart in a few minutes of treatment time, and address many of
the limitations associated with existing surgical, catheter and
pharmacological treatment alternatives. The U.S. FDA granted 510(k)
clearance for the use of the Diamondback Orbital Atherectomy System in
peripheral arteries in August 2007. In October 2013, the company
received FDA approval for the use of the Diamondback Orbital Atherectomy
System in coronary arteries. The Stealth 360® Peripheral Orbital
Atherectomy System (OAS) received CE Mark in October 2014. To date, over
235,000 of CSI's devices have been sold to leading institutions across
the United States. For more information, visit the company's website at www.csi360.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160203005141/en/
[ Back To TMCnet.com's Homepage ]
|
